Tuesday, March 31, 2026

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Trump’s New Tariff Strategy: How Will It Impact EV and Battery Imports in 2026?

Trump plans to expand tariffs on imports deemed national security threats, following a Supreme Court ruling on intergovernmental tariffs.

New USFK Commander Takes Over as North Korea’s Actions Raise Concerns

General Xavier T. Brunson takes command of US Forces Korea amid concerns over North Korea's potential provocations.

Tag: SK Biopharm

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.